Correlation Between Aerovate Therapeutics and Groep Brussel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Groep Brussel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Groep Brussel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Groep Brussel Lambert, you can compare the effects of market volatilities on Aerovate Therapeutics and Groep Brussel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Groep Brussel. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Groep Brussel.

Diversification Opportunities for Aerovate Therapeutics and Groep Brussel

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and Groep is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Groep Brussel Lambert in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Groep Brussel Lambert and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Groep Brussel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Groep Brussel Lambert has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Groep Brussel go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Groep Brussel

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.52 times more return on investment than Groep Brussel. However, Aerovate Therapeutics is 1.93 times less risky than Groep Brussel. It trades about -0.02 of its potential returns per unit of risk. Groep Brussel Lambert is currently generating about -0.05 per unit of risk. If you would invest  263.00  in Aerovate Therapeutics on September 12, 2024 and sell it today you would lose (3.00) from holding Aerovate Therapeutics or give up 1.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Groep Brussel Lambert

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Groep Brussel Lambert 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Groep Brussel Lambert has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Aerovate Therapeutics and Groep Brussel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Groep Brussel

The main advantage of trading using opposite Aerovate Therapeutics and Groep Brussel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Groep Brussel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Groep Brussel will offset losses from the drop in Groep Brussel's long position.
The idea behind Aerovate Therapeutics and Groep Brussel Lambert pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data